Search results for "Farber disease"

showing 8 items of 8 documents

A case of combined Farber and Sandhoff disease

1989

We describe a patient with the biochemically established combination of Farber and Sandhoff disease. A 6-month-old girl of consanguineous Turkish parents presented with hoarseness, stridor, scattered skin nodules, painful swelling of hand joints and ankles, and cherry-red macular spots. Until the age of 2 years her motor and physical condition deteriorated distinctly, however her mental state remained unchanged. A biopsied skin nodule disclosed lysosomal inclusions within storage cells that were typical of Farber disease (curved tubular structures). However, other inclusions (e.g. zebra bodies) were also found. Biochemical findings included ceramide accumulation in skin nodules and cultured…

medicine.medical_specialtyCeramidePathologyBiopsySandhoff diseaseCeramidesLipid Metabolism Inborn Errorschemistry.chemical_compoundInternal medicinemedicineHumansHexosaminidaseSkinSphingolipidsFarber diseasebusiness.industryInfantSandhoff DiseaseCeramidasemedicine.diseaseSkin NoduleEndocrinologyCeramidase activitychemistryPediatrics Perinatology and Child HealthFemalebusinessSphingomyelinEuropean Journal of Pediatrics
researchProduct

A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects

1985

A 20-month-old girl showed typical clinical signs of Farber disease: hoarseness since birth, and periarticular subcutaneous painful nodules. Complete deficiency of acid ceramidase activity was found in cultured skin fibroblasts. An electron microscopic examination of a dermal nodule disclosed pathognomonic tubular inclusions in histiocytes. In epidermal cells zebra-body-like and needle-like lysosomal inclusions were found. Their ultrastructure is different from that of the intrahistiocytic lysosomal inclusions. Probably three clinical types of Farber disease may be distinguished according to the symptomatology and the course of the disease: a severe type, an intermediate type and a relative…

AdultPathologymedicine.medical_specialtyAcid CeramidaseAmidohydrolasesPathognomonicArthropathyCeramidasesmedicineHumansLipomatosisLymphocytesHistiocyteSkinFarber diseaseGranulomaHoarsenessbusiness.industryClinical coursemedicine.diseaseIntermediate typeAcid CeramidasePediatrics Perinatology and Child HealthUltrastructureFemaleJoint DiseasesbusinessEuropean Journal of Pediatrics
researchProduct

Intraepidermal morphologic manifestations in lysosomal diseases.

1989

This paper reports the ultrastructural findings for the epidermis of biopsied skin specimens in numerous lysosomal diseases, which can be grouped as follows: a) presence of vacuolar lysosomal residual bodies in mucopolysaccharidoses I, II and III, Salla disease, GM 2 -gangliosidoses and infantile type II glycogenosis; b) avacuolar lysosomal residual bodies in Niemann-Pick disease type C, mucolipidosis IV, Farber disease, Fabry disease, and late infantile and juvenile neuronal ceroid-lipofuscinoses; c) absence of lysosomal residual bodies in GM 2 -gangliosidoses, metachromatic leukodystrophy, Gaucher disease and sialidosis type III Whenever possible, a biopsy of the skin for morphological di…

Pathologymedicine.medical_specialtyBiologyGangliosidosesDevelopmental NeuroscienceLysosomeBiopsymedicineHumansSialidosisSkinInclusion BodiesFarber diseasemedicine.diagnostic_testGeneral Medicinemedicine.diseaseFabry diseaseMetachromatic leukodystrophyMicroscopy Electronmedicine.anatomical_structureSalla diseasePediatrics Perinatology and Child HealthImmunologyNeurology (clinical)LysosomesMetabolism Inborn ErrorsBraindevelopment
researchProduct

Farber disease (acid ceramidase deficiency) epidemiology: literature review and patient cohort data indicate moderate and attenuated phenotypes are l…

2017

medicine.medical_specialtyFarber diseasePathologybusiness.industryEndocrinology Diabetes and Metabolismmedicine.diseaseBiochemistryPhenotypeAcid Ceramidase Deficiency03 medical and health sciences0302 clinical medicineEndocrinology030220 oncology & carcinogenesisInternal medicineCohortEpidemiologyGeneticsMedicinebusinessMolecular Biology030217 neurology & neurosurgeryMedical literatureMolecular Genetics and Metabolism
researchProduct

An 18-month-old girl with hoarseness, stiff joints and subcutaneous nodules

1998

Farber diseasemedicine.medical_specialtybusiness.industryStiff jointsmedia_common.quotation_subjectInfantFibroblastsmedicine.diseaseSurgeryLysosomal Storage DiseasesCentral nervous system diseaseSubcutaneous nodulePediatrics Perinatology and Child HealthmedicineHumansFemaleGirlbusinessmedia_commonEuropean Journal of Pediatrics
researchProduct

Farber disease: design of the first observational and cross-sectional cohort study capturing retrospective and prospective data on the natural histor…

2017

0301 basic medicineDisease specificPediatricsmedicine.medical_specialtyFarber diseasebusiness.industryEndocrinology Diabetes and MetabolismProspective data030105 genetics & hereditymedicine.diseaseBiochemistryNatural history03 medical and health sciences0302 clinical medicineEndocrinologyGeneticsmedicineObservational studybusinessMolecular Biology030217 neurology & neurosurgeryCohort studyMolecular Genetics and Metabolism
researchProduct

Acid Ceramidase Deficiency

2015

Abstract A deficiency of the lysosomal enzyme ceramidase leads to accumulation of the sphingolipid ceramide in several organs such as skin, liver, brain and other tissues, resulting in a broad spectrum of clinical manifestations. The most common form, called Farber lipogranulomatosis, is characterized by subcutaneous skin nodules and a progressive hoarseness, in many cases also the central nervous system is affected. A lethal hydrops fetalis represents the most severe form. A ceramidase deficiency was also found in a few patients in whom neurological symptoms such as spinal muscular atrophy and myoclonus epilepsy dominated the clinical picture. In the ceramidase gene, which has been mapped …

medicine.medical_specialtyFarber diseasePathologyGenetic enhancementCentral nervous systemProgressive myoclonus epilepsySpinal muscular atrophyBiologyCeramidasemedicine.diseaseSphingolipidEndocrinologymedicine.anatomical_structureHydrops fetalisInternal medicinemedicine
researchProduct

Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease.

2000

Farber's disease (FD) is a rare genetic disorder caused by ceramidase deficiency, which results in ceramide accumulation in lung, liver, colon, skeletal muscle, cartilage, and bone. Although this disease has been symptomatically characterized, little is known about its molecular pathogenetic process. Because recent studies reported that ceramide accumulation induces GD3 ganglioside formation and apoptosis, we investigated, in tissue obtained via colonoscopy from seriously involved patients, the possible involvement of ceramide in FD colonocyte destruction. Histochemical and TUNEL analyses of paraffin-embedded sections revealed that 45 ± 4.3% of FD colonocytes showed morphological signs of …

AdultCeramidePathologymedicine.medical_specialtyHistologyColonCaspase 3ApoptosisCeramideschemistry.chemical_compoundGangliosidesmedicineGD3 gangliosideHumansIntestinal MucosaCaspaseFarber diseaseFarber diseaseTUNEL assaybiologyCaspase 3ApoptosiCell Biologymedicine.diseaseCeramidaseCaspaseK18EpitheliumActive caspase-3Lysosomal Storage Diseasesmedicine.anatomical_structurechemistryApoptosisCaspasesCancer researchbiology.proteinAnatomyActive caspase-3; Apoptosis; Caspases; Farber disease; GD3 ganglioside; K18; Anatomy; Cell BiologyThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
researchProduct